5 Results for "

type II pneumocyte

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "type II pneumocyte" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-12642A
CAS No.: 90-89-1
Purity:  99.83%
Diethylcarbamazine is an orally active microfilaricidal agent used originally in onchocerciasis and lymphatic filiariasis. Diethylcarbamazine reduces eosinophil trafficking to the lung tissue and exerts anti-allergic effects. Diethylcarbamazine reduces serum levels of leptin, TNF-α, IL-6, MCP-1, glucose, insulin, and triglycerides, and ameliorates insulin resistance without altering body, liver, or adipose tissue weights. Diethylcarbamazine enhances reactive oxygen intermediate expression by polymorphonuclear neutrophils, increases lymphocyte proliferation, and inhibits actinomycetoma lesion development. Diethylcarbamazine can be used for the researches of bronchial asthma, insulin resistance and infection .
loading...
    loading...
Cat. No.: HY-P3674
CAS No.: 38482-71-2
Target:  

GnRH Receptor

Research Areas:  

Endocrinology

LH-RH (7-10) is a tetrapeptide, one of major degradation products of luteinising-hormone releasing hormone (LHRH) via pituitary and hypothalamus. LH-RH (7-10) produced in macrophages, type I-like and type II pneumocytes .
loading...
    loading...
Cat. No.: HY-P3675
CAS No.: 51776-33-1
Target:  

GnRH Receptor

Research Areas:  

Endocrinology

LH-RH (4-10) is a heptapeptide, one of major degradation products of luteinising-hormone releasing hormone (LHRH) via pituitary and hypothalamus. LH-RH (4-10) produced in macrophages and type II pneumocytes .
loading...
    loading...
Cat. No.: HY-U00267
CAS No.: 4320-13-2
Target:  

Cholinesterase (ChE)

Research Areas:  

Inflammation/Immunology

Thiazinamium (chloride) possesses potent anticholinergic and antiallergic activity and inhibits TxB2 synthesis with IC50 value of 0.2 µM. Thiazinamium (chloride) is structurally similar to H-1 antagonists Promethazine (HY-B1296). Thiazinamium (chloride) stimulates the phosphatidylcholine secretion in adult rat type II pneumocytes .
loading...
    loading...
Cat. No.: HY-189065
CAS No.: 2765654-79-1
Target:  

LRRK2

Research Areas:  

Neurological Disease

STF-3600 is a LRRK2 G2019S inhibitor with an IC50 of 0.9 nM against the human target. It has oral activity and can cross the blood-brain barrier. STF-3600 selectively inhibits kinase activity, including autophosphorylation at Ser935 and Ser1292, as well as phosphorylation of the endogenous substrate Rab10 at Thr73. STF-3600 inhibits vacuolization of type II pulmonary epithelial cells in wild-type/heterozygous mice, while it induces this vacuolization phenotype in homozygous mice. STF-3600 can be used in Parkinson's disease research .
loading...
    loading...